Review



d ribose  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress d ribose
    D Ribose, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+ribose/D-Ribose/pm42849556-51-74-76
    Average 93 stars, based on 8 article reviews
    d ribose - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    CMC:

    Article Title: Sishen pill alleviates DSS induced colitis through AGE/RAGE/NLRP3 pathway based on transcriptomics analysis.
    Article Snippet: Mesalazine was from EthyPharm Pharmaceutical Co., Ltd. (Shanghai, China). .. Proteintech (Nanjing, China) provided experimental antibodies, FPS-ZM1, CMC-NA, and D-ribose were obtained from Med Chem Express (USA), and ELISA kits for IL-6, IL-13, and IL-1βwere from Beyotime Corporation (Nanjing, China). .. In contrast, the tissue RNA purification kits, reverse transcription kits, and miRNA RT-qPCR kits were provided by EZBioscience Co., Ltd.

    Enzyme-linked Immunosorbent Assay:

    Article Title: Sishen pill alleviates DSS induced colitis through AGE/RAGE/NLRP3 pathway based on transcriptomics analysis.
    Article Snippet: Mesalazine was from EthyPharm Pharmaceutical Co., Ltd. (Shanghai, China). .. Proteintech (Nanjing, China) provided experimental antibodies, FPS-ZM1, CMC-NA, and D-ribose were obtained from Med Chem Express (USA), and ELISA kits for IL-6, IL-13, and IL-1βwere from Beyotime Corporation (Nanjing, China). .. In contrast, the tissue RNA purification kits, reverse transcription kits, and miRNA RT-qPCR kits were provided by EZBioscience Co., Ltd.

    other:

    Article Title: Aqueous extract of Saposhnikovia divaricata root alleviates rheumatoid arthritis by acting on TNF-α and RAGE signaling pathways
    Article Snippet: Saffron-O and Fast Green Kit (G1371) was purchased from Beijing Solarbio Technology Co., LTD (Beijing China).

    Control:

    Article Title: Purine availability determines survival of complex I-deficient fibroblasts under OXPHOS-reliant condition.
    Article Snippet: Growing fibroblasts in medium containing galactose instead of glucose makes cells more dependent on oxidative phosphorylation (OXPHOS) rather than glycolysis.. Recently, it has been shown that treatment with nicotinamide adenine dinucleotide (NAD) improves cell viability of human OXPHOS Complex I-deficient skin fibroblasts in this OXPHOS-reliant condition.. To study the effects of NAD precursors in this model, we supplemented the cells with trigonelline (TG), nicotinamide (NAM), nicotinamide riboside (NR), nicotinamide mononucleotide (NMN) and found no improvement in cell viability, while supplementation with niacin (NA) did partially.

    In Vitro:

    Article Title: Tumor-derived HMGB1 induces CD62L dim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer
    Article Snippet: .. The following reagents/additives were used for in vitro neutrophils intervention. (1) concentrated tissue and cell culture supernatant obtained by ultrafiltration tube centrifugation at 3000 × g for 15 min in Fig. (Millipore, #UFC900396) (2) TLR agonist including Pam3CSK4 (10 ng/mL, TLR2/TLR1 agonist, InvivoGen, #tlrl-pms), FSL-1(10 ng/mL, TLR2/6 agonist, InvivoGen, #tlrl-fsl), Poly(I:C) (LMW) (100 ng/ml, TLR3 agonist, InvivoGen, #tlrl-picw), MPLA-SM (1 μg/mL, TLR4 agonist, InvivoGen, #tlrl-mpla), FLA-ST (1 μg/mL, TLR5 agonist, InvivoGen, #tlrl-stfla), R848 (1 μg/mL, TLR7/8 agonist, InvivoGen, #tlrl-r848), TLR9 Agonist Kit containing ODN 1585, ODN 1826, ODN 2395 (1 μg/mL, TLR9 agonist, InvivoGen, #tlrl-kit9m) in Fig. ; (3) D-Ribose (mixture of isomers, RAGE agonist, MCE, #HY-W018772) in Fig. ; (4) O-Vanillin (100 μM, TLR1/2 & TLR2/6 inhibitor, Sigma-Aldrich, #120804) in Fig. ; (5) TAK242 (10 μM, TLR4 inhibitor, MCE, #HY-11109) in Fig. ; (6) TTP488 (4 nM, RAGE inhibitor, Selleck, #S6415) in Fig. ; (7) recombinant murine HMGB1 protein (Biolegend, #764004) in Fig. and recombinant human HMGB1 protein (Biolegend, #557804) in Fig. ; (8) HMGB1 inhibitor, including glycyrrhizic acid (200 μM, Sigma-Aldrich, #PHR1516) and ethyl pyruvate (1 mM, Sigma-Aldrich, #E47808) were added (Fig. ). (9) 20% human serum including healthy donor, TNBC and non-TNBC in Fig. ; Neutrophils were harvested 4 h later for flow cytometry analysis or RT-PCR. ..

    Cell Culture:

    Article Title: Tumor-derived HMGB1 induces CD62L dim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer
    Article Snippet: .. The following reagents/additives were used for in vitro neutrophils intervention. (1) concentrated tissue and cell culture supernatant obtained by ultrafiltration tube centrifugation at 3000 × g for 15 min in Fig. (Millipore, #UFC900396) (2) TLR agonist including Pam3CSK4 (10 ng/mL, TLR2/TLR1 agonist, InvivoGen, #tlrl-pms), FSL-1(10 ng/mL, TLR2/6 agonist, InvivoGen, #tlrl-fsl), Poly(I:C) (LMW) (100 ng/ml, TLR3 agonist, InvivoGen, #tlrl-picw), MPLA-SM (1 μg/mL, TLR4 agonist, InvivoGen, #tlrl-mpla), FLA-ST (1 μg/mL, TLR5 agonist, InvivoGen, #tlrl-stfla), R848 (1 μg/mL, TLR7/8 agonist, InvivoGen, #tlrl-r848), TLR9 Agonist Kit containing ODN 1585, ODN 1826, ODN 2395 (1 μg/mL, TLR9 agonist, InvivoGen, #tlrl-kit9m) in Fig. ; (3) D-Ribose (mixture of isomers, RAGE agonist, MCE, #HY-W018772) in Fig. ; (4) O-Vanillin (100 μM, TLR1/2 & TLR2/6 inhibitor, Sigma-Aldrich, #120804) in Fig. ; (5) TAK242 (10 μM, TLR4 inhibitor, MCE, #HY-11109) in Fig. ; (6) TTP488 (4 nM, RAGE inhibitor, Selleck, #S6415) in Fig. ; (7) recombinant murine HMGB1 protein (Biolegend, #764004) in Fig. and recombinant human HMGB1 protein (Biolegend, #557804) in Fig. ; (8) HMGB1 inhibitor, including glycyrrhizic acid (200 μM, Sigma-Aldrich, #PHR1516) and ethyl pyruvate (1 mM, Sigma-Aldrich, #E47808) were added (Fig. ). (9) 20% human serum including healthy donor, TNBC and non-TNBC in Fig. ; Neutrophils were harvested 4 h later for flow cytometry analysis or RT-PCR. ..

    Centrifugation:

    Article Title: Tumor-derived HMGB1 induces CD62L dim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer
    Article Snippet: .. The following reagents/additives were used for in vitro neutrophils intervention. (1) concentrated tissue and cell culture supernatant obtained by ultrafiltration tube centrifugation at 3000 × g for 15 min in Fig. (Millipore, #UFC900396) (2) TLR agonist including Pam3CSK4 (10 ng/mL, TLR2/TLR1 agonist, InvivoGen, #tlrl-pms), FSL-1(10 ng/mL, TLR2/6 agonist, InvivoGen, #tlrl-fsl), Poly(I:C) (LMW) (100 ng/ml, TLR3 agonist, InvivoGen, #tlrl-picw), MPLA-SM (1 μg/mL, TLR4 agonist, InvivoGen, #tlrl-mpla), FLA-ST (1 μg/mL, TLR5 agonist, InvivoGen, #tlrl-stfla), R848 (1 μg/mL, TLR7/8 agonist, InvivoGen, #tlrl-r848), TLR9 Agonist Kit containing ODN 1585, ODN 1826, ODN 2395 (1 μg/mL, TLR9 agonist, InvivoGen, #tlrl-kit9m) in Fig. ; (3) D-Ribose (mixture of isomers, RAGE agonist, MCE, #HY-W018772) in Fig. ; (4) O-Vanillin (100 μM, TLR1/2 & TLR2/6 inhibitor, Sigma-Aldrich, #120804) in Fig. ; (5) TAK242 (10 μM, TLR4 inhibitor, MCE, #HY-11109) in Fig. ; (6) TTP488 (4 nM, RAGE inhibitor, Selleck, #S6415) in Fig. ; (7) recombinant murine HMGB1 protein (Biolegend, #764004) in Fig. and recombinant human HMGB1 protein (Biolegend, #557804) in Fig. ; (8) HMGB1 inhibitor, including glycyrrhizic acid (200 μM, Sigma-Aldrich, #PHR1516) and ethyl pyruvate (1 mM, Sigma-Aldrich, #E47808) were added (Fig. ). (9) 20% human serum including healthy donor, TNBC and non-TNBC in Fig. ; Neutrophils were harvested 4 h later for flow cytometry analysis or RT-PCR. ..

    Recombinant:

    Article Title: Tumor-derived HMGB1 induces CD62L dim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer
    Article Snippet: .. The following reagents/additives were used for in vitro neutrophils intervention. (1) concentrated tissue and cell culture supernatant obtained by ultrafiltration tube centrifugation at 3000 × g for 15 min in Fig. (Millipore, #UFC900396) (2) TLR agonist including Pam3CSK4 (10 ng/mL, TLR2/TLR1 agonist, InvivoGen, #tlrl-pms), FSL-1(10 ng/mL, TLR2/6 agonist, InvivoGen, #tlrl-fsl), Poly(I:C) (LMW) (100 ng/ml, TLR3 agonist, InvivoGen, #tlrl-picw), MPLA-SM (1 μg/mL, TLR4 agonist, InvivoGen, #tlrl-mpla), FLA-ST (1 μg/mL, TLR5 agonist, InvivoGen, #tlrl-stfla), R848 (1 μg/mL, TLR7/8 agonist, InvivoGen, #tlrl-r848), TLR9 Agonist Kit containing ODN 1585, ODN 1826, ODN 2395 (1 μg/mL, TLR9 agonist, InvivoGen, #tlrl-kit9m) in Fig. ; (3) D-Ribose (mixture of isomers, RAGE agonist, MCE, #HY-W018772) in Fig. ; (4) O-Vanillin (100 μM, TLR1/2 & TLR2/6 inhibitor, Sigma-Aldrich, #120804) in Fig. ; (5) TAK242 (10 μM, TLR4 inhibitor, MCE, #HY-11109) in Fig. ; (6) TTP488 (4 nM, RAGE inhibitor, Selleck, #S6415) in Fig. ; (7) recombinant murine HMGB1 protein (Biolegend, #764004) in Fig. and recombinant human HMGB1 protein (Biolegend, #557804) in Fig. ; (8) HMGB1 inhibitor, including glycyrrhizic acid (200 μM, Sigma-Aldrich, #PHR1516) and ethyl pyruvate (1 mM, Sigma-Aldrich, #E47808) were added (Fig. ). (9) 20% human serum including healthy donor, TNBC and non-TNBC in Fig. ; Neutrophils were harvested 4 h later for flow cytometry analysis or RT-PCR. ..

    Flow Cytometry:

    Article Title: Tumor-derived HMGB1 induces CD62L dim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer
    Article Snippet: .. The following reagents/additives were used for in vitro neutrophils intervention. (1) concentrated tissue and cell culture supernatant obtained by ultrafiltration tube centrifugation at 3000 × g for 15 min in Fig. (Millipore, #UFC900396) (2) TLR agonist including Pam3CSK4 (10 ng/mL, TLR2/TLR1 agonist, InvivoGen, #tlrl-pms), FSL-1(10 ng/mL, TLR2/6 agonist, InvivoGen, #tlrl-fsl), Poly(I:C) (LMW) (100 ng/ml, TLR3 agonist, InvivoGen, #tlrl-picw), MPLA-SM (1 μg/mL, TLR4 agonist, InvivoGen, #tlrl-mpla), FLA-ST (1 μg/mL, TLR5 agonist, InvivoGen, #tlrl-stfla), R848 (1 μg/mL, TLR7/8 agonist, InvivoGen, #tlrl-r848), TLR9 Agonist Kit containing ODN 1585, ODN 1826, ODN 2395 (1 μg/mL, TLR9 agonist, InvivoGen, #tlrl-kit9m) in Fig. ; (3) D-Ribose (mixture of isomers, RAGE agonist, MCE, #HY-W018772) in Fig. ; (4) O-Vanillin (100 μM, TLR1/2 & TLR2/6 inhibitor, Sigma-Aldrich, #120804) in Fig. ; (5) TAK242 (10 μM, TLR4 inhibitor, MCE, #HY-11109) in Fig. ; (6) TTP488 (4 nM, RAGE inhibitor, Selleck, #S6415) in Fig. ; (7) recombinant murine HMGB1 protein (Biolegend, #764004) in Fig. and recombinant human HMGB1 protein (Biolegend, #557804) in Fig. ; (8) HMGB1 inhibitor, including glycyrrhizic acid (200 μM, Sigma-Aldrich, #PHR1516) and ethyl pyruvate (1 mM, Sigma-Aldrich, #E47808) were added (Fig. ). (9) 20% human serum including healthy donor, TNBC and non-TNBC in Fig. ; Neutrophils were harvested 4 h later for flow cytometry analysis or RT-PCR. ..



    Similar Products

    93
    MedChemExpress d ribose
    D Ribose, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+ribose/D-Ribose/pm42849556-51-74-76
    Average 93 stars, based on 1 article reviews
    d ribose - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress ribose 5 phosphate
    PNP promoted GMP proliferation and enhanced myeloid cell production via inosine-5′-monophosphate dehydrogenase 2 (IMPDH2). Violin plot presenting PNP expression in GMPs and subpopulations by scRNA-seq analysis. ( A–F ) BMCs were exposed to PNP (0–1 U/mL) for 24 and 72 h. FACS analysis of the frequency of HSPCs, GMPs, and Pro-NEU. ( G–I ) After 3 days of PNP treatment, the proportion of neutrophils and monocytes in BMCs was quantified by FACS. ( J–Q ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for <t>24</t> <t>h.</t> <t>Ribose-5-phosphate</t> and IMPDH2 expression was measured by ELISA. BMCs were treated with PNP in the absence or presence of IMPDH2 inhibitor for 24 h. EDU + GMPs were analyzed by FACS. In parallel, the frequency of HSPCs, GMP, Pro-NEU, and cMOP was analyzed by FACS. ( R–S ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 72 h. Neutrophil and monocyte production were evaluated by FACS. BMC: bone marrow cell; ELISA: enzyme-linked immunosorbent assay; FACS: fluorescence-activated cell sorting; GMP: granulocyte-monocyte progenitor; HSPC: hematopoietic stem/progenitor cell; Pro-NEU, Pro-neutrophils; cMOP, common monocyte progenitors; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; PNP: purine nucleoside phosphorylase; scRNA-seq: single-cell RNA sequencing. Two experimental groups were compared using the unpaired two-tailed Student's t-test. In the experiments involving ≥3 groups, one-way analysis of variance followed by Dunnett's test was used.
    Ribose 5 Phosphate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+ribose/D-Ribose+5-phosphate/pmc13085009-365-13-54
    Average 93 stars, based on 1 article reviews
    ribose 5 phosphate - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Biosynth Carbosynth d ribose
    PNP promoted GMP proliferation and enhanced myeloid cell production via inosine-5′-monophosphate dehydrogenase 2 (IMPDH2). Violin plot presenting PNP expression in GMPs and subpopulations by scRNA-seq analysis. ( A–F ) BMCs were exposed to PNP (0–1 U/mL) for 24 and 72 h. FACS analysis of the frequency of HSPCs, GMPs, and Pro-NEU. ( G–I ) After 3 days of PNP treatment, the proportion of neutrophils and monocytes in BMCs was quantified by FACS. ( J–Q ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for <t>24</t> <t>h.</t> <t>Ribose-5-phosphate</t> and IMPDH2 expression was measured by ELISA. BMCs were treated with PNP in the absence or presence of IMPDH2 inhibitor for 24 h. EDU + GMPs were analyzed by FACS. In parallel, the frequency of HSPCs, GMP, Pro-NEU, and cMOP was analyzed by FACS. ( R–S ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 72 h. Neutrophil and monocyte production were evaluated by FACS. BMC: bone marrow cell; ELISA: enzyme-linked immunosorbent assay; FACS: fluorescence-activated cell sorting; GMP: granulocyte-monocyte progenitor; HSPC: hematopoietic stem/progenitor cell; Pro-NEU, Pro-neutrophils; cMOP, common monocyte progenitors; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; PNP: purine nucleoside phosphorylase; scRNA-seq: single-cell RNA sequencing. Two experimental groups were compared using the unpaired two-tailed Student's t-test. In the experiments involving ≥3 groups, one-way analysis of variance followed by Dunnett's test was used.
    D Ribose, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+ribose/D-Ribose/pmc13041761-268-37-44
    Average 93 stars, based on 1 article reviews
    d ribose - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Aladdin Scientific Corporation d ribose d rib
    PNP promoted GMP proliferation and enhanced myeloid cell production via inosine-5′-monophosphate dehydrogenase 2 (IMPDH2). Violin plot presenting PNP expression in GMPs and subpopulations by scRNA-seq analysis. ( A–F ) BMCs were exposed to PNP (0–1 U/mL) for 24 and 72 h. FACS analysis of the frequency of HSPCs, GMPs, and Pro-NEU. ( G–I ) After 3 days of PNP treatment, the proportion of neutrophils and monocytes in BMCs was quantified by FACS. ( J–Q ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for <t>24</t> <t>h.</t> <t>Ribose-5-phosphate</t> and IMPDH2 expression was measured by ELISA. BMCs were treated with PNP in the absence or presence of IMPDH2 inhibitor for 24 h. EDU + GMPs were analyzed by FACS. In parallel, the frequency of HSPCs, GMP, Pro-NEU, and cMOP was analyzed by FACS. ( R–S ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 72 h. Neutrophil and monocyte production were evaluated by FACS. BMC: bone marrow cell; ELISA: enzyme-linked immunosorbent assay; FACS: fluorescence-activated cell sorting; GMP: granulocyte-monocyte progenitor; HSPC: hematopoietic stem/progenitor cell; Pro-NEU, Pro-neutrophils; cMOP, common monocyte progenitors; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; PNP: purine nucleoside phosphorylase; scRNA-seq: single-cell RNA sequencing. Two experimental groups were compared using the unpaired two-tailed Student's t-test. In the experiments involving ≥3 groups, one-way analysis of variance followed by Dunnett's test was used.
    D Ribose D Rib, supplied by Aladdin Scientific Corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+ribose/D-Ribose/pm41638272-41-4-66
    Average 94 stars, based on 1 article reviews
    d ribose d rib - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Shanghai Aladdin Bio-Chem d ribose rib
    PNP promoted GMP proliferation and enhanced myeloid cell production via inosine-5′-monophosphate dehydrogenase 2 (IMPDH2). Violin plot presenting PNP expression in GMPs and subpopulations by scRNA-seq analysis. ( A–F ) BMCs were exposed to PNP (0–1 U/mL) for 24 and 72 h. FACS analysis of the frequency of HSPCs, GMPs, and Pro-NEU. ( G–I ) After 3 days of PNP treatment, the proportion of neutrophils and monocytes in BMCs was quantified by FACS. ( J–Q ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for <t>24</t> <t>h.</t> <t>Ribose-5-phosphate</t> and IMPDH2 expression was measured by ELISA. BMCs were treated with PNP in the absence or presence of IMPDH2 inhibitor for 24 h. EDU + GMPs were analyzed by FACS. In parallel, the frequency of HSPCs, GMP, Pro-NEU, and cMOP was analyzed by FACS. ( R–S ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 72 h. Neutrophil and monocyte production were evaluated by FACS. BMC: bone marrow cell; ELISA: enzyme-linked immunosorbent assay; FACS: fluorescence-activated cell sorting; GMP: granulocyte-monocyte progenitor; HSPC: hematopoietic stem/progenitor cell; Pro-NEU, Pro-neutrophils; cMOP, common monocyte progenitors; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; PNP: purine nucleoside phosphorylase; scRNA-seq: single-cell RNA sequencing. Two experimental groups were compared using the unpaired two-tailed Student's t-test. In the experiments involving ≥3 groups, one-way analysis of variance followed by Dunnett's test was used.
    D Ribose Rib, supplied by Shanghai Aladdin Bio-Chem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+ribose/d+d+rib+ribose/pm41519324-47-5-14
    Average 86 stars, based on 1 article reviews
    d ribose rib - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    93
    Thermo Fisher iron iii chloride
    PNP promoted GMP proliferation and enhanced myeloid cell production via inosine-5′-monophosphate dehydrogenase 2 (IMPDH2). Violin plot presenting PNP expression in GMPs and subpopulations by scRNA-seq analysis. ( A–F ) BMCs were exposed to PNP (0–1 U/mL) for 24 and 72 h. FACS analysis of the frequency of HSPCs, GMPs, and Pro-NEU. ( G–I ) After 3 days of PNP treatment, the proportion of neutrophils and monocytes in BMCs was quantified by FACS. ( J–Q ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for <t>24</t> <t>h.</t> <t>Ribose-5-phosphate</t> and IMPDH2 expression was measured by ELISA. BMCs were treated with PNP in the absence or presence of IMPDH2 inhibitor for 24 h. EDU + GMPs were analyzed by FACS. In parallel, the frequency of HSPCs, GMP, Pro-NEU, and cMOP was analyzed by FACS. ( R–S ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 72 h. Neutrophil and monocyte production were evaluated by FACS. BMC: bone marrow cell; ELISA: enzyme-linked immunosorbent assay; FACS: fluorescence-activated cell sorting; GMP: granulocyte-monocyte progenitor; HSPC: hematopoietic stem/progenitor cell; Pro-NEU, Pro-neutrophils; cMOP, common monocyte progenitors; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; PNP: purine nucleoside phosphorylase; scRNA-seq: single-cell RNA sequencing. Two experimental groups were compared using the unpaired two-tailed Student's t-test. In the experiments involving ≥3 groups, one-way analysis of variance followed by Dunnett's test was used.
    Iron Iii Chloride, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+ribose/2-Deoxy-D-ribose%2C+99%25/pm41418953-48-2-11
    Average 93 stars, based on 1 article reviews
    iron iii chloride - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    86
    Fisher Scientific 2 deoxy d ribose
    PNP promoted GMP proliferation and enhanced myeloid cell production via inosine-5′-monophosphate dehydrogenase 2 (IMPDH2). Violin plot presenting PNP expression in GMPs and subpopulations by scRNA-seq analysis. ( A–F ) BMCs were exposed to PNP (0–1 U/mL) for 24 and 72 h. FACS analysis of the frequency of HSPCs, GMPs, and Pro-NEU. ( G–I ) After 3 days of PNP treatment, the proportion of neutrophils and monocytes in BMCs was quantified by FACS. ( J–Q ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for <t>24</t> <t>h.</t> <t>Ribose-5-phosphate</t> and IMPDH2 expression was measured by ELISA. BMCs were treated with PNP in the absence or presence of IMPDH2 inhibitor for 24 h. EDU + GMPs were analyzed by FACS. In parallel, the frequency of HSPCs, GMP, Pro-NEU, and cMOP was analyzed by FACS. ( R–S ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 72 h. Neutrophil and monocyte production were evaluated by FACS. BMC: bone marrow cell; ELISA: enzyme-linked immunosorbent assay; FACS: fluorescence-activated cell sorting; GMP: granulocyte-monocyte progenitor; HSPC: hematopoietic stem/progenitor cell; Pro-NEU, Pro-neutrophils; cMOP, common monocyte progenitors; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; PNP: purine nucleoside phosphorylase; scRNA-seq: single-cell RNA sequencing. Two experimental groups were compared using the unpaired two-tailed Student's t-test. In the experiments involving ≥3 groups, one-way analysis of variance followed by Dunnett's test was used.
    2 Deoxy D Ribose, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+ribose/2+d+deoxy+ribose/pm41384323-278-17-19
    Average 86 stars, based on 1 article reviews
    2 deoxy d ribose - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Shanghai Aladdin Bio-Chem d ribose d rib
    PNP promoted GMP proliferation and enhanced myeloid cell production via inosine-5′-monophosphate dehydrogenase 2 (IMPDH2). Violin plot presenting PNP expression in GMPs and subpopulations by scRNA-seq analysis. ( A–F ) BMCs were exposed to PNP (0–1 U/mL) for 24 and 72 h. FACS analysis of the frequency of HSPCs, GMPs, and Pro-NEU. ( G–I ) After 3 days of PNP treatment, the proportion of neutrophils and monocytes in BMCs was quantified by FACS. ( J–Q ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for <t>24</t> <t>h.</t> <t>Ribose-5-phosphate</t> and IMPDH2 expression was measured by ELISA. BMCs were treated with PNP in the absence or presence of IMPDH2 inhibitor for 24 h. EDU + GMPs were analyzed by FACS. In parallel, the frequency of HSPCs, GMP, Pro-NEU, and cMOP was analyzed by FACS. ( R–S ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 72 h. Neutrophil and monocyte production were evaluated by FACS. BMC: bone marrow cell; ELISA: enzyme-linked immunosorbent assay; FACS: fluorescence-activated cell sorting; GMP: granulocyte-monocyte progenitor; HSPC: hematopoietic stem/progenitor cell; Pro-NEU, Pro-neutrophils; cMOP, common monocyte progenitors; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; PNP: purine nucleoside phosphorylase; scRNA-seq: single-cell RNA sequencing. Two experimental groups were compared using the unpaired two-tailed Student's t-test. In the experiments involving ≥3 groups, one-way analysis of variance followed by Dunnett's test was used.
    D Ribose D Rib, supplied by Shanghai Aladdin Bio-Chem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+ribose/d+d+rib+ribose/pm41376063-40-0-12
    Average 86 stars, based on 1 article reviews
    d ribose d rib - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results


    PNP promoted GMP proliferation and enhanced myeloid cell production via inosine-5′-monophosphate dehydrogenase 2 (IMPDH2). Violin plot presenting PNP expression in GMPs and subpopulations by scRNA-seq analysis. ( A–F ) BMCs were exposed to PNP (0–1 U/mL) for 24 and 72 h. FACS analysis of the frequency of HSPCs, GMPs, and Pro-NEU. ( G–I ) After 3 days of PNP treatment, the proportion of neutrophils and monocytes in BMCs was quantified by FACS. ( J–Q ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 24 h. Ribose-5-phosphate and IMPDH2 expression was measured by ELISA. BMCs were treated with PNP in the absence or presence of IMPDH2 inhibitor for 24 h. EDU + GMPs were analyzed by FACS. In parallel, the frequency of HSPCs, GMP, Pro-NEU, and cMOP was analyzed by FACS. ( R–S ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 72 h. Neutrophil and monocyte production were evaluated by FACS. BMC: bone marrow cell; ELISA: enzyme-linked immunosorbent assay; FACS: fluorescence-activated cell sorting; GMP: granulocyte-monocyte progenitor; HSPC: hematopoietic stem/progenitor cell; Pro-NEU, Pro-neutrophils; cMOP, common monocyte progenitors; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; PNP: purine nucleoside phosphorylase; scRNA-seq: single-cell RNA sequencing. Two experimental groups were compared using the unpaired two-tailed Student's t-test. In the experiments involving ≥3 groups, one-way analysis of variance followed by Dunnett's test was used.

    Journal: Redox Biology

    Article Title: Alpha-ketoglutarate accelerates granulocyte-monocyte progenitor differentiation and atherosclerotic plaque inflammation via oxoglutarate receptor 1

    doi: 10.1016/j.redox.2026.104134

    Figure Lengend Snippet: PNP promoted GMP proliferation and enhanced myeloid cell production via inosine-5′-monophosphate dehydrogenase 2 (IMPDH2). Violin plot presenting PNP expression in GMPs and subpopulations by scRNA-seq analysis. ( A–F ) BMCs were exposed to PNP (0–1 U/mL) for 24 and 72 h. FACS analysis of the frequency of HSPCs, GMPs, and Pro-NEU. ( G–I ) After 3 days of PNP treatment, the proportion of neutrophils and monocytes in BMCs was quantified by FACS. ( J–Q ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 24 h. Ribose-5-phosphate and IMPDH2 expression was measured by ELISA. BMCs were treated with PNP in the absence or presence of IMPDH2 inhibitor for 24 h. EDU + GMPs were analyzed by FACS. In parallel, the frequency of HSPCs, GMP, Pro-NEU, and cMOP was analyzed by FACS. ( R–S ) Lineage −/low cells were treated with 0 or 0.1 U/mL PNP for 72 h. Neutrophil and monocyte production were evaluated by FACS. BMC: bone marrow cell; ELISA: enzyme-linked immunosorbent assay; FACS: fluorescence-activated cell sorting; GMP: granulocyte-monocyte progenitor; HSPC: hematopoietic stem/progenitor cell; Pro-NEU, Pro-neutrophils; cMOP, common monocyte progenitors; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; PNP: purine nucleoside phosphorylase; scRNA-seq: single-cell RNA sequencing. Two experimental groups were compared using the unpaired two-tailed Student's t-test. In the experiments involving ≥3 groups, one-way analysis of variance followed by Dunnett's test was used.

    Article Snippet: Protein was extracted from PNP-treated lineage −/low cells to determine the expression of ribose-5-phosphate, IMPDH2, NAD, SOD, and ATP by ELISA, following the manufacturer's instructions (mouse IMPDH2 ELISA kit [#ml601123], mouse NAD ELISA kit [# JK691233 ], Enzyme-linked Biotechnology, China; mouse SOD ELISA kit [#CSB- E08556 m], Huamei Bioengineering, China; ATP Assay Kit [#HY-K0314], MedChemExpress, US).

    Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Fluorescence, FACS, Single Cell, RNA Sequencing, Two Tailed Test

    Correlation of LDL-c and TCA metabolites in human plasma samples. (A-B) The fasting plasma levels of LDL-c and isocitrate were determined in healthy human subjects (n = 40) and their correlation was analyzed by Spearman's correlation analysis. ATP: adenosine triphosphate; ELISA: enzyme-linked immunosorbent assay; GPX: glutathione peroxidase; LDL-c: low-density lipoprotein cholesterol; NAD: nicotinamide adenine dinucleotide; PNP: purine nucleoside phosphorylase; ROS: reactive oxygen species; SOD: superoxide dismutase. (C) A proposed model of HFD-induced skewed myelopoiesis and atherosclerosis via α-ketoglutarate. In mice fed a HFD, isocitrate was elevated and LDL-c increased isocitrate dehydrogenase expression, leading to enhanced α-ketoglutarate production. Acting through OXGR1, α-ketoglutarate upregulated PNP mRNA and protein expression. PNP catabolized guanosine/deoxyguanosine and inosine/deoxyinosine, generating ribose-1-phosphate. By interconversion, ribose-5-phosphate production was increased and initiated de novo purine biosynthesis, resulting in IMPDH2 production and GMP proliferation. PNP metabolized nicotinamide riboside to Nam, decreasing NMN and NAD production. PNP increased NAD kinase expression to further accelerate NAD consumption. Furthermore, PNP increased inflammatory protein expression such as NF-κB. All of which reduced NAD production promoted ROS production and inflammation to facilitate GMP differentiation. Ultimately, the pronounced GMP proliferation and differentiation led to inflammatory myeloid cell production and atherosclerotic progression. GMP: granulocyte-monocyte progenitor; HFD: high-fat diet; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; LDL-c: low-density lipoprotein cholesterol; NAD: nicotinamide adenine dinucleotide; OXGR1: oxoglutarate receptor 1; PNP: purine nucleoside phosphorylase; ROS: reactive oxygen species.

    Journal: Redox Biology

    Article Title: Alpha-ketoglutarate accelerates granulocyte-monocyte progenitor differentiation and atherosclerotic plaque inflammation via oxoglutarate receptor 1

    doi: 10.1016/j.redox.2026.104134

    Figure Lengend Snippet: Correlation of LDL-c and TCA metabolites in human plasma samples. (A-B) The fasting plasma levels of LDL-c and isocitrate were determined in healthy human subjects (n = 40) and their correlation was analyzed by Spearman's correlation analysis. ATP: adenosine triphosphate; ELISA: enzyme-linked immunosorbent assay; GPX: glutathione peroxidase; LDL-c: low-density lipoprotein cholesterol; NAD: nicotinamide adenine dinucleotide; PNP: purine nucleoside phosphorylase; ROS: reactive oxygen species; SOD: superoxide dismutase. (C) A proposed model of HFD-induced skewed myelopoiesis and atherosclerosis via α-ketoglutarate. In mice fed a HFD, isocitrate was elevated and LDL-c increased isocitrate dehydrogenase expression, leading to enhanced α-ketoglutarate production. Acting through OXGR1, α-ketoglutarate upregulated PNP mRNA and protein expression. PNP catabolized guanosine/deoxyguanosine and inosine/deoxyinosine, generating ribose-1-phosphate. By interconversion, ribose-5-phosphate production was increased and initiated de novo purine biosynthesis, resulting in IMPDH2 production and GMP proliferation. PNP metabolized nicotinamide riboside to Nam, decreasing NMN and NAD production. PNP increased NAD kinase expression to further accelerate NAD consumption. Furthermore, PNP increased inflammatory protein expression such as NF-κB. All of which reduced NAD production promoted ROS production and inflammation to facilitate GMP differentiation. Ultimately, the pronounced GMP proliferation and differentiation led to inflammatory myeloid cell production and atherosclerotic progression. GMP: granulocyte-monocyte progenitor; HFD: high-fat diet; IMPDH2: inosine-5′-monophosphate dehydrogenase 2; LDL-c: low-density lipoprotein cholesterol; NAD: nicotinamide adenine dinucleotide; OXGR1: oxoglutarate receptor 1; PNP: purine nucleoside phosphorylase; ROS: reactive oxygen species.

    Article Snippet: Protein was extracted from PNP-treated lineage −/low cells to determine the expression of ribose-5-phosphate, IMPDH2, NAD, SOD, and ATP by ELISA, following the manufacturer's instructions (mouse IMPDH2 ELISA kit [#ml601123], mouse NAD ELISA kit [# JK691233 ], Enzyme-linked Biotechnology, China; mouse SOD ELISA kit [#CSB- E08556 m], Huamei Bioengineering, China; ATP Assay Kit [#HY-K0314], MedChemExpress, US).

    Techniques: Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Expressing